Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1115418 BOSTON, MA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$15,844,011
+$4,503,891 QoQ
Shares Held
50,125
-11.8% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#67
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. LGND ranks #21 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,844,011 50,125
2026-03-31 $11,340,120 56,800
2025-12-31 $10,727,075 56,736
2025-09-30 $10,526,013 59,422
2025-06-30 $6,764,869 59,508
2025-03-31 $6,040,923 57,456
2024-12-31 $6,369,531 59,445
2024-09-30 $6,007,401 60,020
2024-06-30 $5,167,834 61,332
2024-03-31 $4,404,640 60,255
2023-12-31 $4,251,275 59,525
2023-09-30 $3,423,049 57,127
2023-06-30 $4,001,477 55,499
2023-03-31 $3,901,695 53,041
2022-12-31 $3,386,693 50,699
2022-09-30 $4,176,935 48,507
2022-06-30 $4,268,638 47,844
2022-03-31 $5,177,579 46,027
2021-12-31 $6,951,161 45,003
2021-09-30 $6,438,113 46,211
2021-06-30 $6,641,100 50,622
2021-03-31 $6,938,759 45,515
2020-12-31 $4,555,404 45,806
2020-09-30 $4,364,702 45,790
2020-06-30 $6,116,850 54,688
2020-03-31 $4,536,560 62,384